Sign in

CIK 0001001233

  • Non-accelerated filer
  • Smaller reporting company

SANGAMO THERAPEUTICS, INC

Sign in to watch
Ticker
SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680359556
Phone
+1 510-970-6000
Business address
501 CANAL BLVD., RICHMOND, CA, 94084
Former names
SANGAMO BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-25 McClung David Mark EVP, Chief Operating Officer Grant or award · Stock Option (Right to Buy) +160,380 160,380
2022-02-25 Macrae Sandy President, CEO and Director Shares withheld for taxes −49,890 $5.90 $294K 297,176
2022-02-25 Macrae Sandy President, CEO and Director Grant or award +224,000 521,176
2022-02-25 Macrae Sandy President, CEO and Director Grant or award · Stock Option (Right to Buy) +604,800 604,800
2022-02-25 Zakrzewski Joseph S Director Grant or award +12,500 60,700
2022-02-25 Zakrzewski Joseph S Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-25 Smith Karen L. Director Grant or award +12,500 38,200
2022-02-25 Smith Karen L. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-25 Ramasastry Saira Director Grant or award +12,500 35,700
2022-02-25 Ramasastry Saira Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-25 PARKER H STEWART Director Grant or award +12,500 43,700
2022-02-25 PARKER H STEWART Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-25 Meyers James R Director Grant or award +12,500 35,700
2022-02-25 Meyers James R Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-25 Markels John Director Grant or award +12,500 25,700
2022-02-25 Markels John Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-25 Hillan Kenneth J. Director Grant or award +12,500 35,700
2022-02-25 Hillan Kenneth J. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-25 Carey Robert Director Grant or award +12,500 35,700
2022-02-25 Carey Robert Director Grant or award · Stock Option (Right to Buy) +25,000 25,000

Page 14 of 17 · 338 trades